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Abstract
Rheumatoid arthritis is the most common systematic autoimmune disease and its etiology is
believed to have both strong genetic and environmental components. We demonstrate the utility
of including genetic and clinical phenotypes as covariates within a linkage analysis framework to
search for rheumatoid arthritis susceptibility loci. The raw genotypes of 1302 affected relative pairs
were combined from four large family-based samples (North American Rheumatoid Arthritis
Consortium, United Kingdom, European Consortium on Rheumatoid Arthritis Families, and
Canada). The familiality of the clinical phenotypes was assessed. The affected relative pairs were
subjected to autosomal multipoint affected relative-pair linkage analysis. Covariates were included
in the linkage analysis to take account of heterogeneity within the sample. Evidence of familiality
was observed with age at onset (p << 0.001) and rheumatoid factor (RF) IgM (p << 0.001), but not
definite erosions (p  = 0.21). Genome-wide significant evidence for linkage was observed on
chromosome 6. Genome-wide suggestive evidence for linkage was observed on chromosomes 13
and 20 when conditioning on age at onset, chromosome 15 conditional on gender, and
chromosome 19 conditional on RF IgM after allowing for multiple testing of covariates.
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Background
Rheumatoid arthritis (RA) is the most common system-
atic autoimmune disease and is believed to have both
strong genetic and environmental components in its etiol-
ogy. Females are at a higher risk than males and their age
at presentation shows considerable variability [1]. Here
we describe an analysis of a combined sample of raw gen-
otypes provided by Genetic Analysis Workshop 15
(GAW15), comprising four family-based samples known
by their collection center as NARAC (North American
Rheumatoid Arthritis Consortium), UK (United King-
dom), ECRAF (European Consortium on Rheumatoid
Arthritis Families), and Canada. The aim of the analysis
was to investigate the familiality of clinical phenotypes
and then employ them and genetic phenotypes as covari-
ates in a linkage analysis framework to allow us to inves-
tigate models, such as locus heterogeneity, that give rise to
different phenotypes within RA.
Methods
Autosomal microsatellite data for the NARAC, UK, and
ECRAF samples were combined with the Illumina single-
nucleotide polymorphism (SNP) sample from Canada.
The genotypic data were stored in sample-specific files
and their marker maps were aligned to improve map cor-
respondence between samples. The Canada and ECRAF
loci were placed on the NARAC and UK genetic map using
the NCBI physical positions of NARAC, ECRAF, and Can-
ada loci – see Segurado et al. [2] for more detail. Non-Cau-
casians were removed from the NARAC sample to
minimize heterogeneity. No ethnicity information was
available for the UK, ECRAF, and Canada samples. The
software GRR [3] was used to identify potentially incorrect
inheritance structures within pedigrees. These pedigrees
were subsequently removed from further analyses. No
Mendelian inheritance errors were detected with Ped-
Check [4].
Linkage disequilibrium (LD)
We removed evidence of LD to minimize the chance of
excessive false positives [5]. Microsatellite markers sepa-
rated by less than 0.5 cM were identified and those with
the lowest single-point information content were
removed. The SNP map was thinned to a 0.5 cM grid on
the basis of location. Any remaining SNP pairs with an r2
> 0.05 and separated by less than 5 cM were thinned fur-
ther until no LD remained.
Phenotypes
The genetic and clinical phenotypes analyzed were gender
(binary), age at onset (AAO; continuous), definite erosion
(binary), and rheumatoid factor (RF) IgM (four levels;
treated as continuous). The ECRAF and Canada pheno-
type information available was limited to gender and RA
status. The RA susceptibility locus HLA-DRB1 on chromo-
some 6 was also investigated. We defined a binary meas-
ure for HLA to represent whether an individual carried a
high risk allele, as described in the GAW15 Problem 2
data description [1]. An individual was coded as HLA+ if
they carried at least one copy of the five high risk alleles,
i.e., DRB1*0401, 0404, 0405, 0408, or 0409. HLA- was
defined as no copies of the seven medium increased risk
(i.e., DRB1*0101, 0102, 0104, 0105, 1001, 1402, 1406)
or the five high risk alleles.
Statistical analysis
The familiality of the phenotypes AAO, definite erosion,
and RF in the individuals affected with RA was assessed in
a mixed-effects regression framework by taking the phe-
notype of interest as the dependent variable, imple-
mented in the software packages MIXOR [6] and MIXREG
[7]. Intra-class correlation coefficients (ICCs) were esti-
mated and indicate the proportion of unexplained vari-
ance attributable to family membership, i.e., the strength
of the familial effect.
Multipoint model-free affected relative-pair (ARP) linkage
analysis was performed with the raw phenotypes AAO,
definite erosion, RF, HLA, and gender included as covari-
ates (in separate analyses). Sample-specific allele frequen-
cies and pair-wise IBD (identity-by-descent) allele sharing
probabilities using information from the full pedigree
were estimated by MERLIN [8] at 2 cM intervals. For each
chromosome, the IBD estimates from the four samples
were combined into a single file. Assuming the maternal
and paternal alleles to be inherited independently, the
allele sharing probability, pr, can be modelled in a logistic
regression framework and can be written as logit(pr) = O +
α + βx, where O is a fixed offset that depends on the rela-
tionship between the pair, α is a measure of divergence of
IBD from the null in the sample as a whole, and β incor-
porates covariate x into the model. Because the parame-
ters pr, O, and α are based on pairs of individuals, so must
be the covariate parameter. When considering a continu-
ous measure, covariates were constructed for the mean
and difference for each pair. A binary measure (- or +) was
resolved into either -/-, -/+, or +/+ pairs of individuals. For
further information on including covariates in the model
and constraining the parameters, see Hamshere et al. [9].
The IBD estimates and covariate data were then used to
estimate the allele sharing probability pr, given particular
covariates, and then to obtain ARP linkage statistics.
Because HLA resides on chromosome 6, no HLA covariate
analysis was performed on chromosome 6.
For each chromosome and covariate, two multipoint LOD
scores were produced at each 2-cM position: i) the covari-
ate LOD score and ii) a univariate LOD score, in only the
ARPs included in the covariate analysis, i.e., excluding
those with missing covariate data. An increase in the max-BMC Proceedings 2007, 1(Suppl 1):S100 http://www.biomedcentral.com/1753-6561/1/S1/S100
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imum LOD score over the chromosome (i–ii; ILOD) in
excess of 2.0 was taken to indicate a potential covariate
effect. Empirical significance levels for each LOD score
peak in the observed data were obtained as follows:
10,000 replicates of chromosome 22 were simulated in
the absence of linkage, using the same pedigree structures,
marker locations, marker allele frequencies and missing
genotype patterns as the original data. The average
number of peaks per chromosome reaching the required
height was calculated from these replicates (note: peaks
were defined as local maxima in the LOD score curve sep-
arated by at least 30 cM). The number of peaks per
genome was approximated by multiplying by 60 (since
the length of chromosome 22 is approximately 1/60 of
the total length of the autosomes in this sample). This
procedure gives similar results to those obtained by simu-
lating replicates of all 22 chromosomes (data not shown),
and is considerably easier computationally. Correction for
the multiple testing of six non-independent genome scans
was applied as follows. First, criteria were chosen for each
covariate to give the same significance level (i.e., number
of peaks expected by chance per genome scan) as the test
peak. Then, for each replicate chromosome, the locations
and heights of all the peaks from all six covariates were
combined into a single list, and the total number of peaks
greater than their corresponding criterion was obtained.
The distance criterion of 30 cM for defining separate peaks
ensured that peaks from several covariates that are close
together (i.e., non-independence) were counted only
once. The expected number of peaks per genome was cal-
culated as before. Following Lander and Kruglyak [10], we
called peaks in the observed data "genome-wide signifi-
cant" if the expected number of peaks per genome at least
as high as in the simulated data was ≤ 0.05, and "genome-
wide suggestive" if this quantity was < 1.0.
Results
The sample comprised 1302 ARPs informative for linkage
from 982 pedigrees, originating from 633 (466) NARAC,
494 (370) UK, 117 (88) ECRAF, and 58 (58) Canada sam-
ples of ARPs (pedigrees). The NARAC and UK samples
contributed a total of 61 non-sibling ARPs. Estimates of
the ICCs indicate the familiality of each phenotype and
are presented in Table 1. We observed genome-wide sig-
nificant evidence for linkage on chromosome 6. Three
other chromosomal regions were identified with a univar-
iate LOD score > 1.0 but did not reach the criteria for
genome-wide suggestive linkage; these were found on
chromosomes 12, 16, and 18. Linkage covariate analyses
produced one, two, and one chromosomes with genome-
wide suggestive evidence for linkage when gender, AAO,
and RF were included in the model, respectively (see Table
2). Neither the HLA nor definite erosion covariates pro-
duced increases in maximum LOD score > 2.0.
Discussion
The highly significant clustering of AAO and RF within
pedigrees replicates the evidence observed in monozy-
gotic twins [11], suggesting they make good candidates
for inclusion in the linkage analysis framework. We do
not see similar clustering with definite erosions, although
because 90% of the individuals have had a definite ero-
sion, there is little power to detect clustering within fami-
lies or difference in the allele sharing probabilities.
The maximum LOD score of 20.73 at 46 cM on chromo-
some 6 is by far the most convincing evidence for linkage
that we observe. This peak is at the location of the genetic
locus HLA, which is thought to contribute 30 to 50% of
the total genetic component of RA [12,13]. We also
observe evidence for loci on chromosomes 12, 16, and 18,
the size of their genetic effect is considerably less than that
of HLA. Evidence for all four loci was also observed by
Etzel et al. [14] and in the extended sample of GAW15 [2],
using the SNP instead of microsatellite data where availa-
ble. There was no evidence observed for any locus × locus
interaction effects with HLA (tested as a binary covariate).
This suggests that the regions on chromosomes 12, 16,
and 18, if true linkages, may harbor genes that act inde-
pendently of HLA. Our HLA measure excluded individu-
als who carried medium but no high risk alleles. Two
additional HLA measures were created, where the seven
medium risk alleles contribute to 1) the HLA+ group and
2) the HLA- group. The linkage results were unchanged. It
is possible that we have lost important HLA allelic infor-
mation when creating our binary HLA measure. Also, if
HLA is not the actual disease gene, but in LD with a dis-
ease-causing mutation of relatively large effect, as sug-
Table 1: Phenotype descriptive statistics, intraclass correlation coefficients (ICCs)
Phenotypea Mean SD N ICC pICC
b No. ARPs No. pedigrees
Gender 0.61 0.49 7213 - - 1302 982
AAO (years) 39.84 13.51 2405 0.38 <<0.001 1030 786
Definite erosion 0.90 0.30 2063 0.08 0.21 789 630
RF 1.99 1.16 2083 0.18 <<0.001 785 608
HLA 0.76 0.42 2430 - - 870 662
aBinary measures: - or male: 0, + or female: 1.
bpICC is not corrected for multiple testing.BMC Proceedings 2007, 1(Suppl 1):S100 http://www.biomedcentral.com/1753-6561/1/S1/S100
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gested by the very large LOD on chromosome 6, a
covariate analysis with the binary HLA measure may be
less powerful than using a covariate based on the IBD
information [15], especially if not all individuals have
HLA genotypes. To investigate this further we performed
covariate analyses conditional on the chromosome 6 IBD
information (30 to 80 cM), producing two regions with
an ILOD > 2.0, both having chromosome-wide signifi-
cance (see Table 3). We do not replicate the interaction
found by John et al. [16] with chromosome 6 (30 to 120
cM) and chromosome 16 observed in the NARAC and UK
samples (chromosome-wide p = 0.323).
A benefit of combining the raw genotypes of samples is
that the power to detect disease susceptibility loci of small
effect is increased. However, it is possible that pooling
samples introduces heterogeneity. Incorporating origin of
sample as a covariate in the analysis detected evidence of
allele sharing heterogeneity only on chromosome 12
(chromosome-wide p = 0.04; IBD estimates of NARAC:
0.46, UK: 0.47, ECRAF: 0.61, Canada: 0.58 at 104 cM),
suggesting that heterogeneity is minimal. Each of the cov-
ariate regions of interest were analyzed in the separate
samples, e.g., NARAC only. All regions showed similar
effects in the separate samples as in the combined sample.
The inclusion of gender, AAO, and RF as covariates pro-
duced some potential regions of interest. We observed evi-
dence for an AAO covariate effect on chromosome 1
(expected to occur by chance 1.467 times per genome
scan) within 7 cM of an effect observed by analyzing only
NARAC and UK individuals with an AAO < 40 years [16].
Our method of incorporating covariates allows all indi-
viduals to be included in the analysis and for a direct com-
parison with the model without the covariate as they are
based on the same sample size. We do not replicate the
results for AAO, erosion, or HLA in the ECRAF sample
[17] (we do not have access to this phenotype data); both
[16,17] analyzed peak regions of interest.
The RF data we analyzed were ordinal (four levels). This
was the highest common form of the data as the original
data were a combination of ordinal (UK) and continuous
(NARAC). We subjected chromosome 19 to further scru-
tiny by analyzing the NARAC sample with RF as continu-
ous data. We did not replicate the results. The distribution
of the continuous RF data is very highly positively skewed,
with no obvious outliers. Of the total sample, 45% of the
continuous RF data was coded as 4 (high positive) in the
ordinal RF measure. We transformed the data with log10,
loge, and square root to produce a distribution more sim-
ilar to the normal distribution – our linkage results were
unchanged. This suggests that i) the distribution of the
continuous covariate is not important and ii) the chromo-
some 19 RF result may be an artifact of creating an ordinal
measure from continuous data and analyzing it as a con-
tinuous measure.
We also considered two family-based methods that use a
single covariate defined for each pedigree: a family-wise
ARP method in which the covariate (e.g., minimum AAO)
Table 2: Summary of LOD scores of interest
Chr Covariate Maximum LOD score (cM) ILODb Covariate allele sharing informationa No. peaks/genome No. peaks/genome (6 scans)
1 AAO 2.52 (228) 2.12 earlier 1.467 6.60
6 - 20.73 (46) - - 0.000 0.00
9 AAO 3.36 (46) 2.80 later & more similar 0.283 1.37
11 Gender 2.38 (70) 2.04 0.61, 0.44, 0.53 1.267 5.78
12 - 1.36 (48) - - 1.467 6.60
13 AAO 3.80 (34) 2.74 earlier 0.124 0.64
15 Gender 3.71 (66) 3.34 0.59, 0.41, 0.50 0.059 0.33
16 - 1.29 (44) - - 1.791 8.00
18 - 1.38 (80) - - 1.361 6.19
19 RF 4.73 (88) 2.36 more similar 0.012 0.07
20 AAO 3.88 (100) 3.28 earlier 0.112 0.59
aFor continuous covariate measures, the region of the distribution with increased allele sharing are given. For the gender covariate (M, male; F, 
female), the M/M, M/F and F/F allele sharing probabilities at the maximum LOD score location are presented.
bILOD, increase in maximum LOD score.
Table 3: Summary of chromosome-wide significant identity-by-descent (IBD) allele sharing interaction LOD scores
Run chromosome Conditional chromosome Interaction LOD (run cM, conditional cM) Chromosome-wide 
significance
Direction of IBD 
correlation
3 6 3.66 (208, 52) 0.031 +
12 6 3.55 (120, 34) 0.020 +Publish with BioMed Central    and   every 
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is assigned to all ARPs from that family and an ordered
subset analysis (OSA) in which pedigrees are ranked on
their covariate values and sequentially added to the anal-
ysis with FLOSS [18]. We focus on the AAO phenotype
because it was the only measure that presented enough
variability in the sample to be suitable for OSA. We con-
sidered three covariates, the mean, minimum and maxi-
mum AAO, all of which were highly correlated (Pearson r,
p << 0.001). Family-wise ILODs > 2 were observed on
chromosomes 13 and 20, with both mean and maximum
(the minimum measures gave ILODs > 1). OSAs also
identified these two regions; chromosome 13 (maximum:
p = 0.0096, based on n = 80 pedigrees), chromosome 20
(maximum: p = 0.0001, n = 146, mean: p = 0.0002, n =
159; minimum: p = 0.0128, n = 167). The regions identi-
fied with family-wise measures lie within 10 cM and with
the same direction of effect as those identified to be
genome-wide suggestive (after adjusting for six scans)
with the pair-wise measure. The similarity of the results
from the three covariate methods is likely to reflect mini-
mal heterogeneity of AAO within pedigrees, correspond-
ing to the highly significant ICC (p << 0.001) presented in
Table 1.
Conclusion
We provide evidence to support the familiality of AAO
and RF IgM. Incorporating covariates in the linkage anal-
ysis allowed us to identify novel regions that may harbor
RA susceptibility loci. This information may be useful in
conducting future population based case-control analy-
ses, where it will be important to take into account the
particular covariate. Replication in independent samples
will be important to determine whether our findings are
owing to chance alone.
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